Internal Medicine, Hematology · Rochester, MN
NPI
1356350623
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
8,374 services
Medicare patients, 2024
211
Average age 73
Drug cost, 2024
$4.6M
485 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Naseema Gangat was code 99232 (hospital e&m - subsequent), 326 times for 65 patients. In total Naseema Gangat billed 8,374 services in 38 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 326 | 65 | $62.22 | $20K |
| 99214 Office E&M - Established | Office | 76 | 52 | $99.05 | $7,528 |
| 99205 Office E&M - New | Office | 29 | 29 | $161.75 | $4,691 |
| 99215 Office E&M - Established | Office | 28 | 22 | $132.94 | $3,722 |
| 99442 Telephone Services | Office | 25 | 17 | $71.73 | $1,793 |
| 96365 Intravenous Infusion, Hydration | Office | 20 | 20 | $49.91 | $998 |
| 96372 Injection Administration | Office | 12 | 12 | $11.92 | $143 |
By year: 2022 $38K for 497 services; 2023 $138K for 5,854 services; 2024 $110K for 8,374 services.
Medicare prescription drug claims, 2024
In 2024, the drug Naseema Gangat prescribed most often to Medicare patients was Hydroxyurea, with 90 prescriptions and refills. In total Naseema Gangat wrote 485 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 90 | 204 | 28 | $2,792 |
| Jakafi Ruxolitinib Phosphate | 83 | 83 | Under 11 | $1.3M |
| Ojjaara Momelotinib Dihydrochloride | 58 | 58 | Under 11 | $1.6M |
| Sprycel Dasatinib | 25 | 26 | Under 11 | $254K |
| Besremi Ropeginterferon Alfa-2b-Njft | 25 | 25 | Under 11 | $407K |
| Allopurinol Generic | 17 | 51 | Under 11 | $299 |
| Acyclovir Generic | 15 | 19 | Under 11 | $288 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 14 | 14 | Under 11 | $72.89 |
| Venclexta Venetoclax | 11 | 11 | Under 11 | $35K |
| Posaconazole Generic | 11 | 11 | Under 11 | $7,418 |
| Levofloxacin Generic | 11 | 11 | Under 11 | $187 |
Brand drugs: 261 claims; generic drugs: 224 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Naseema Gangat were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.